185 related articles for article (PubMed ID: 12115839)
1. Formulation pH modulates the interaction of insulin with chitosan nanoparticles.
Ma Z; Yeoh HH; Lim LY
J Pharm Sci; 2002 Jun; 91(6):1396-404. PubMed ID: 12115839
[TBL] [Abstract][Full Text] [Related]
2. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules.
Giovino C; Ayensu I; Tetteh J; Boateng JS
Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987
[TBL] [Abstract][Full Text] [Related]
3. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.
Dyer AM; Hinchcliffe M; Watts P; Castile J; Jabbal-Gill I; Nankervis R; Smith A; Illum L
Pharm Res; 2002 Jul; 19(7):998-1008. PubMed ID: 12180553
[TBL] [Abstract][Full Text] [Related]
4. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
[TBL] [Abstract][Full Text] [Related]
6. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
Krauland AH; Alonso MJ
Int J Pharm; 2007 Aug; 340(1-2):134-42. PubMed ID: 17459620
[TBL] [Abstract][Full Text] [Related]
7. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
9. Chitosan/beta-lactoglobulin core-shell nanoparticles as nutraceutical carriers.
Chen L; Subirade M
Biomaterials; 2005 Oct; 26(30):6041-53. PubMed ID: 15885766
[TBL] [Abstract][Full Text] [Related]
10. Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.
Zheng AP; Wang JC; Lu WL; Zhang X; Zhang H; Wang XQ; Zhang Q
J Nanosci Nanotechnol; 2006; 6(9-10):2936-44. PubMed ID: 17048501
[TBL] [Abstract][Full Text] [Related]
11. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
12. Chitosan microcapsules as controlled release systems for insulin.
Aiedeh K; Gianasi E; Orienti I; Zecchi V
J Microencapsul; 1997; 14(5):567-76. PubMed ID: 9292433
[TBL] [Abstract][Full Text] [Related]
13. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
14. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
He Z; Santos JL; Tian H; Huang H; Hu Y; Liu L; Leong KW; Chen Y; Mao HQ
Biomaterials; 2017 Jun; 130():28-41. PubMed ID: 28359018
[TBL] [Abstract][Full Text] [Related]
15. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
16. Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation.
Sarmento B; Ribeiro AJ; Veiga F; Ferreira DC; Neufeld RJ
J Nanosci Nanotechnol; 2007 Aug; 7(8):2833-41. PubMed ID: 17685304
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration.
Hecq J; Siepmann F; Siepmann J; Amighi K; Goole J
Drug Dev Ind Pharm; 2015; 41(12):2037-44. PubMed ID: 26006329
[TBL] [Abstract][Full Text] [Related]
18. Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Mukhopadhyay P; Sarkar K; Chakraborty M; Bhattacharya S; Mishra R; Kundu PP
Mater Sci Eng C Mater Biol Appl; 2013 Jan; 33(1):376-82. PubMed ID: 25428084
[TBL] [Abstract][Full Text] [Related]
19. Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption.
Fan YF; Wang YN; Fan YG; Ma JB
Int J Pharm; 2006 Nov; 324(2):158-67. PubMed ID: 16814967
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
